About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
F. Randy Vogenberg reviews a new book by Michael P. Cecil, MD, that should be a resource for consumers, health care professionals, and Medicare-eligible beneficiaries despite some complications brought about by the new Medicare Part D regulations.
F. Randy Vogenberg, RPh, PhD
Health Care and Law
Pennsylvania becomes the newest state in which pharmacists will be playing a larger role in the drug prescription process: they will have the authority to adjust drug regimens, order laboratory and diagnostic tests, and administer medications.
Robert I. Field, JD, MPH, PhD
Management of Community-Acquired Respiratory Tract Infections in an Era of Increasing Antibiotic Resistance
The authors discuss the extent of the problem of antibiotic resistance in the U.S., assess the clinical and economic ramifications of such resistance, and provide an overview of antibiotics currently available for the empirical treatment of out-patients with community-acquired RTIs.
John A. Sbarbaro, MD, MPH, David P. Nicolau, PharmD, and Carl Asche, PhD
Continuing Education Credit
The author reviews the current understanding of the pathophysiology of congestive heart failure (CHF) and discusses the paradigm shift in thinking about the role of beta blockers in CHF management.
Steven D. Hanks, MD, MMM, FACP
David Nash, MD, MBA, discusses the work of NICE, the National Institute for Health and Clinical Excellence in the United Kingdom, and its implications for health care in the U.S.
David Nash, MD, MBA
Matthew Grissinger, RPh, FASCP, dispels the notion that not punishing staff members who make mistakes increases carelessness and absolves workers from personal responsibility for patient safety.
Matthew Grissinger, RPh, FASCP
Trend toward Generics Puts Spotlight on Biopharmaceuticals: FDA Slow to Develop Guidelines as Congress and Public Wait Impatiently
Stephen Barlas discusses the reasons for the delay in bringing generic â€œbiotechâ€ drugs to the market.
P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.
Duloxetine HCl (Cymbalta) for the Treatment of Depression, Neuropathic Pain, Fibromyalgia, and Stress Urinary Incontinence
Dr. Cruz and coauthors review duloxetine (Cymbalta) and its uses in depression, neuropathic pain, fibromyalgia, and stress urinary incontinence.
Martin P. Cruz, PharmD, CGP, Michelle E. Gonzales, PharmD, Jennifer Jacobs, PharmD, and Melinda Constante LaFave, PharmD